Asset Dedication’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$100K Sell
475
-15
-3% -$3.01K 0.01% 400
2026
Q2
$93.2K Buy
490
+15
+3% +$2.58K 0.01% 411
2026
Q1
$80.2K Hold
475
– – 0.01% 423
2025
Q4
$80.2K Buy
475
+3
+0.6% +$487 0.01% 427
2025
Q3
$68.1K Hold
472
– – ﹤0.01% 472
2025
Q2
$59.7K Hold
472
– – ﹤0.01% 493
2025
Q1
$60.4K Hold
472
– – ﹤0.01% 455
2024
Q4
$62.4K Hold
472
– – ﹤0.01% 439
2024
Q3
$68.7K Hold
472
– – ﹤0.01% 460
2024
Q2
$64.8K Hold
472
– – ﹤0.01% 457
2024
Q1
$65K Buy
472
+342
+263% +$46.7K ﹤0.01% 409
2023
Q4
$18K Hold
130
– – ﹤0.01% 593
2023
Q3
$16K Hold
130
– – ﹤0.01% 602
2023
Q2
$17K Hold
130
– – ﹤0.01% 587
2023
Q1
$17K Buy
130
+30
+30% +$3.93K ﹤0.01% 580
2022
Q4
$13K Hold
100
– – ﹤0.01% 619
2022
Q3
$12K Buy
+100
New +$12.4K ﹤0.01% 596
2022
Q2
– Sell
-100
Closed -$13K – 694
2022
Q1
$13K Hold
100
– – ﹤0.01% 622
2021
Q4
$15K Hold
100
– – ﹤0.01% 590
2021
Q3
$16K Hold
100
– – ﹤0.01% 605
2021
Q2
$16K Hold
100
– – ﹤0.01% 554
2021
Q1
$15K Hold
100
– – ﹤0.01% 460
2020
Q4
$15K Sell
100
-50
-33% -$7.15K ﹤0.01% 496
2020
Q3
$20K Sell
150
-657
-81% -$89.1K ﹤0.01% 447
2020
Q2
$111K Sell
807
-146
-15% -$18.6K 0.03% 251
2020
Q1
$103K Buy
953
+53
+6% +$6.1K 0.03% 254
2019
Q4
$108K Hold
900
– – 0.03% 233
2019
Q3
$89K Hold
900
– – 0.03% 234
2019
Q2
$99K Hold
900
– – 0.03% 223
2019
Q1
$100K Hold
900
– – 0.03% 215
2018
Q4
$86K Hold
900
– – 0.04% 212
2018
Q3
$110K Hold
900
– – 0.04% 193
2018
Q2
$99K Hold
900
– – 0.03% 209
2018
Q1
$96K Hold
900
– – 0.05% 178
2017
Q4
$96K Hold
900
– – 0.04% 183
2017
Q3
$100K Hold
900
– – 0.05% 159
2017
Q2
$93K Hold
900
– – 0.05% 169
2017
Q1
$88K Hold
900
– – 0.05% 168
2016
Q4
$79K Sell
900
-333
-27% -$30.3K 0.05% 173
2016
Q3
$118K Buy
1,233
+333
+37% +$31.7K 0.07% 145
2016
Q2
$77K Hold
900
– – 0.05% 166
2016
Q1
$78K Sell
900
-1,683
-65% -$151K 0.06% 152
2015
Q4
$291K Buy
+2,583
New +$280K 0.19% 117

Other funds holding IBB

Asset Dedication's IBB Position: Q3 2026 in Review

Asset Dedication reduced its iShares Biotechnology ETF (IBB) stake by 3.1% in Q3 2026, selling an estimated $3.01K and leaving 475 shares worth $100K. The position accounts for 0.01% of the portfolio, ranked #400.

Asset Dedication first reported a position in IBB in Q4 2015 and has held it in 43 quarters since. The position peaked at $291K in Q4 2015. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Asset Dedication held 475 shares of iShares Biotechnology ETF worth $100K as of Q3 2026.
  • Asset Dedication sold 15 iShares Biotechnology ETF shares in Q3 2026, an estimated $3.01K.
  • iShares Biotechnology ETF made up 0.01% of Asset Dedication's portfolio in Q3 2026, its #400 holding.
  • Asset Dedication first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 43 quarters since.
  • Asset Dedication's iShares Biotechnology ETF position peaked at $291K in Q4 2015.
  • 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.